We are conducting clinical research studies to better understand cognitive disorders, including Alzheimer’s disease, Mild Cognitive Impairment (MCI), Lewy Body Dementia, and Frontotemporal Lobar Degeneration (FTLD). Our goal is to improve diagnosis, treatment options, and quality of life for individuals and families affected by memory or thinking changes.
If you are interested in seeing if you are eligible for one of our studies, please call our Cognitive and Memory Disorders clinical research team at 614-293-6882 or email cognitive@osumc.edu.
Diversity in clinical trials for Alzheimer's disease
Ohio State is committed to ensuring Alzheimer’s disease clinical trials reflect our population. We're not all the same physiologically, whether it's because of age, illness, or genetic ancestry, and we likely all metabolize drugs differently. Because of this, it's imperative that clinical trials include underrepresented groups. When study volunteers participate in research, society benefits, bringing new hope to patients afflicted with different diseases or conditions.